CBD of Denver, Inc.

CBD of Denver, Inc.

CBDD
CBD of Denver, Inc.US flagOther OTC
0.00
USD
- -
- -
1.07MMarket Cap
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChatGPT
CEO
Axel Reinke
Full Time Employees
2
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
6436 South Quebec Street Centennial CO United States of America 80111
IPO Date
May 15, 1996
Business
CBD of Denver Inc. (OTC: CBDD) operates as a diversified asset acquisition company focused on acquiring, nurturing, and enhancing profitable business assets, with core activities in cannabis wholesale strategies, technology-driven solutions, and high-margin consumer products. The company develops and commercializes cannabidiol (CBD) and hemp-derived products, including premium hemp extracts, cannabis flower, and hemp oils; offers innovative consumer brands such as Black Pearl CBD, Rockflowr, and CBD Social Network; and provides advanced cannabinoid testing through handheld near-infrared (NIR) spectroscopy devices via its subsidiary Luxora, enabling rapid, non-destructive product analysis with subscription-based services. It engages in research, development, production, and distribution of these offerings primarily through wholesale operations targeting health, wellness, and cannabis sectors, serving customers in the United States, Switzerland, and broader Europe. Founded in 1993 and headquartered in Centennial, Colorado, CBD of Denver Inc. functions as a subsidiary of Swiss Industry Ventures AG and was formerly known as Verde Media Group, Inc. prior to its name change in 2018. The company reported strong financial performance for fiscal year 2024, with revenue increasing 26% to $3.75 million, driven by its wholesale CBD division and Luxora operations, alongside robust April and May 2024 sales reaching approximately $490,000. In mid-2024, it unwound its acquisition of Libra 9 GmbH due to unmet revenue targets, accepted the resignation of CEO Axel Reinke, and appointed Jan Schwager, CEO of Luxora, as new CEO; it also signed a letter of intent with Alchemy Games Co. Ltd. in early 2025 for blockchain-based payment processing and digital infrastructure partnerships, signaling a strategic expansion into technology sectors. These moves reflect a pivot toward operational efficiency, regulatory agility, and accretive opportunities amid evolving European cannabis market dynamics.

Company News

APIChatGPT
  • CBD of Denver, Inc. (CBDD) Advances Evaluation of AI-Driven Health & Wellness Acquisition Opportunity

  • CBD of Denver Announces Updated Corporate Website Reflecting Strategic Pivot into Artificial Intelligence

  • CBD of Denver Announces Strategic Exploration of Merger Candidates

  • CBD of Denver, Inc. Identifies Strategic Opportunities to Maximize Shareholder Value

  • CBD of Denver Expands Into the Tech Sector with Strategic LOI Signing

  • CBD of Denver Achieves 26% Revenue Growth and Returns to Positive Operating Income in 2024

  • CBD of Denver Reflects on 2024 and Announces Withdrawal from German Market Amid Political Uncertainty

  • CBD of Denver Announces Q3 Revenue and Updates on Spinoff and German Market

  • CBD of Denver, Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2024

  • CBD of Denver Announces Q2 Revenue and Provides Update on German Market

  • CBD of Denver Announces June Revenue and Successful Exhibition at Mary Jane Trade Fair in Berlin

  • CBD of Denver Inc. Announces Strong April and May Sales

  • CBD of Denver Inc. Announces Filing of Q1 Quarterly Disclosure and Financials

  • CBD of Denver Inc. Announces Annual Disclosure and Filing of Financial Statements

  • CBD of Denver Inc. Announces New Advisory Board Member for Luxora

  • CBD of Denver Inc. Reports Q1 Revenue

  • CBD of Denver Inc. Reports January Revenue, Progress on Legislation in Germany and Business Highlights

  • CBD of Denver Inc. Announces Continued Growth for Q4, Reflecting on Building a Successful Year

  • CBD of Denver Announces Launch of Luxora Real Estate

  • CBD of Denver Inc. Announces Sustained Growth for Luxora, a New Supply Agreement with a Swiss Wholesaler, and the Signing of Additional Letters of Intent